Literature DB >> 28216193

Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients.

Angelique Fan1, Bruno Pereira2, Anne Tournadre1, Zuzana Tatar1, Sandrine Malochet-Guinamand1, Sylvain Mathieu1, Marion Couderc1, Martin Soubrier1, Jean-Jacques Dubost3.   

Abstract

OBJECTIVE: Fibromyalgia (FM) is a confounding factor for diagnosing and assessing rheumatic disease activity. This study sought to assess the extent of this syndrome in rheumatism patients at a French rheumatology department.
METHOD: This monocentric epidemiological study enrolled all patients consulting due to rheumatoid arthritis (RA), spondyloarthritis (SpA), or connective tissue disease (CTD). FM diagnosis was confirmed or excluded according to the rheumatologist opinion and the 1990 American College of Rheumatology (ACR) criteria.
RESULTS: We enrolled 691 patients, including 451 women (65.3%), with a mean age of 55.8 years (18-93). Of the enrolled patients, 325 presented with RA, 298 SpA [59 psoriatic arthritis (PsA), 137 ankylosing spondylitis (AS), 64 non-radiographic SpA (nr-SpA), and 38 peripheral SpA], and 71 CTD. The rheumatologist established FM diagnosis in 97 patients (14%), while 55 (8%) fulfilled the 1990 ACR criteria. The frequency of FM was lower in RA patients (4.9% by 1990 ACR criteria; 7.7% by expert opinion) compared to SpA (11.1% by 1990 ACR, p < 0.05; 17.5% by expert opinion, p < 0.003) and CTD (11.3% by 1990 ACR, non-significant; 28.2% by expert opinion, p < 0.001). In the SpA subgroups, FM was more common in the nr-SpA than in PsA or AS (23.9%, 9.6%, and 6.4%, by 1990 ACR, p = 0.001; 37.3%, 13.5%, and 7.2%, by expert opinion, p < 0.001).
CONCLUSION: FM-like symptoms are commonly associated with rheumatic diseases. The frequency of FM is particularly high in non-radiographic axial SpA, thus raising questions about the specificity of the Assessment of SpondyloArthritis International Society (ASAS) classification criteria.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Connective tissue diseases; Fibromyalgia; Rheumatoid arthritis; Spondyloarthritis

Mesh:

Year:  2017        PMID: 28216193     DOI: 10.1016/j.semarthrit.2017.01.005

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

1.  Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis.

Authors:  Daniela Santos-Faria; Maxime Dougados; Laure Gossec; Serge Perrot; Anna Moltó
Journal:  Rheumatol Int       Date:  2018-11-09       Impact factor: 2.631

2.  Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis.

Authors:  Nada Mahmoud Shresher; Aly Elsayed Mohamed; Mohsen Hassan Elshahaly
Journal:  Rheumatol Int       Date:  2019-08-03       Impact factor: 2.631

Review 3.  Role of comorbidities in spondyloarthritis including psoriatic arthritis.

Authors:  Silvia Scriffignano; Fabio Massimo Perrotta; Antonia De Socio; Ennio Lubrano
Journal:  Clin Rheumatol       Date:  2018-10-18       Impact factor: 2.980

Review 4.  Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis.

Authors:  Stephen J Duffield; Natasha Miller; Sizheng Zhao; Nicola J Goodson
Journal:  Rheumatology (Oxford)       Date:  2018-08-01       Impact factor: 7.580

Review 5.  The Impact of Fibromyalgia in Spondyloarthritis: From Classification Criteria to Outcome Measures.

Authors:  Alessia Alunno; Francesco Carubbi; Simon Stones; Roberto Gerli; Roberto Giacomelli; Xenofon Baraliakos
Journal:  Front Med (Lausanne)       Date:  2018-10-24

6.  The prevalence of fibromyalgia in axial spondyloarthritis.

Authors:  Gareth T Jones; Bhadra Mallawaarachchi; Joanna Shim; Jonathan Lock; Gary J Macfarlane
Journal:  Rheumatol Int       Date:  2020-06-15       Impact factor: 2.631

7.  COVID-19 associated hospitalization in 571 patients with fibromyalgia-A population-based study.

Authors:  Mor Amital; Niv Ben-Shabat; Howard Amital; Dan Buskila; Arnon D Cohen; Daniela Amital
Journal:  PLoS One       Date:  2021-12-30       Impact factor: 3.240

8.  EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.

Authors:  Laure Gossec; Xenofon Baraliakos; Andreas Kerschbaumer; Maarten de Wit; Iain McInnes; Maxime Dougados; Jette Primdahl; Dennis G McGonagle; Daniel Aletaha; Andra Balanescu; Peter V Balint; Heidi Bertheussen; Wolf-Henning Boehncke; Gerd R Burmester; Juan D Canete; Nemanja S Damjanov; Tue Wenzel Kragstrup; Tore K Kvien; Robert B M Landewé; Rik Jozef Urbain Lories; Helena Marzo-Ortega; Denis Poddubnyy; Santiago Andres Rodrigues Manica; Georg Schett; Douglas J Veale; Filip E Van den Bosch; Désirée van der Heijde; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2020-06       Impact factor: 27.973

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.